EHMT2 and lung carcinoma: Recently, abnormal expression of EHMT2 has been discovered in various types of malignant cells, including acute myeloid leukemia, bladder cancer, lung cancer, squamous cell carcinoma, ovarian cancer, etc. 10-12.